Kensey Nash acquires IntraLuminal Therapeutics for $8 million

By Elaine Rigoli

Tampa, Fla., May 26 - Kensey Nash Corp. has acquired substantially all of the assets of IntraLuminal Therapeutics, Inc. for $8 million in cash.

IntraLuminal Therapeutics commercialized the Safe-Cross system in both the United States and Europe and developed a patent portfolio of 19 U.S. and corresponding foreign patents focusing on guidance technology in combination with radiofrequency energy.

The platform technologies have broad therapeutic application for a variety of cardiovascular, surgical, neurological, carotid and men's/women's health procedures, Kensey Nash said in a news release.

Kensey Nash said it plans to use the IntraLuminal Therapeutics technology as a base platform to develop products to meet the clinical needs of the emerging chronic total occlusions market.

Kensey Nash, located in Exton, Pa., is a medical technology company.

IntraLuminal Therapeutics is a medical technology company located in Carlsbad, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.